Evidence based Resources

Debridement is vital in wound bed preparation, creating a clean, moist environment that supports effective healing (Burnett et al, 2021). It facilitates the removal of devitalised tissue, bacteria, and debris, reducing infection risk and promoting healthy tissue growth (Mayer et al, 2024). Multiple debridement techniques exist such as sharp, larval, enzymatic, ultrasound, and surgical, however their use may be limited by required expertise or clinical setting. This article introduces an updated definition of debridement and traces its evolution from traditional methods to modern, patient-friendly technologies, exemplified by the innovative dual-sided monofilament pad, Debrisoft® Duo. It also includes some case series evaluating the effectiveness and practicality of Debrisoft Duo, particularly in managing wounds with persistent fibrous devitalised tissue where conventional sharp debridement is unsuitable.

Moisture-associated skin damage (MASD), particularly incontinence-associated dermatitis (IAD), is a significant challenge in acute care settings. It affects patient comfort, increases the risk of infection, and contributes to prolonged hospital stays (Gray et al, 2021). Effective skin protection strategies, including structured care protocols and barrier products, are essential to mitigate these complications. This case evaluation examines the use of Medi Derma-PRO Ointment to enhance skin integrity and reduce MASDrelated harm across a healthcare trust. An evidence-based approach was employed to evaluate patient and broader organisational outcomes following the implementation of this intervention.

Mark Collier describes how to assess wounds more accurately.
Mark Collier, B.A (Hons), RNT, RCNT, ONC, RN is a Lead Nurse Ð Tissue Viability, United Lincolnshire Hospitals NHS Trust and United Lincolnshire Hospitals Tissue Viability Collaboration (ULHTVC).
Article accepted for publication May 2001.